Search for: "Eli F."
Results 21 - 40
of 674
Sorted by Relevance
|
Sort by Date
5 Jul 2018, 7:20 am
Teva Pharmaceuticals, USA, Inc., 429 F.3d 1364 (Fed. [read post]
5 Jul 2018, 7:20 am
Teva Pharmaceuticals, USA, Inc., 429 F.3d 1364 (Fed. [read post]
23 May 2012, 7:44 am
Answer: If you are currently a B-1, B-2, F-1, M-1 or M-2 and want to extend your status; If you want to change your status to want to B-1, B-2, F-1, F-2, J-1, J-2, M-1 or M-2 ; or if you want to reinstate your status to F-1, F-2, M-1 or M-2. [read post]
23 Feb 2018, 4:15 am
Eli Lilly and Co. v. [read post]
19 Aug 2008, 6:34 pm
My name is ELIE YING MYSTAL, f/k/a SOPHIST, and it looks like I will be taking over day-to-day editorial responsibilities here at Above the Law. [read post]
15 May 2013, 9:09 am
Eli Lilly & Co., 598 F.3d 1336, 1349 (Fed. [read post]
19 Dec 2017, 2:40 pm
Cir. 2017).(...)We recently applied Akamai V’s “two-prong test” inEli Lilly, a Hatch-Waxman suit brought by Eli Lillyagainst several defendants seeking to launch a genericversion of Eli Lilly’s chemotherapy drug. 845 F.3d at1362. [read post]
12 Jan 2017, 12:42 pm
(Eli Lilly III), 126 F. [read post]
6 Nov 2010, 1:05 am
Vor wenigen Tagen startete der Prozess vor dem Hamburger Landgericht gegen Elis. [read post]
25 Nov 2013, 6:00 am
Volkswagen of America, Inc., 603 F.3d 1133, 1134 (9th Cir. 2010). [read post]
15 Mar 2023, 1:30 pm
“Expensively credentialed, negligibly educated Stanford brats threw a tantrum”: Columnist George F. [read post]
8 Jun 2021, 9:15 am
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
27 Jan 2014, 9:47 am
A judgment declaring that the '703 patent remains valid and enforceable; F. [read post]
10 Sep 2010, 6:05 am
* Elie mentioned this yesterday. [read post]
9 Jul 2022, 1:35 pm
Michael-Corey F. [read post]
28 Jul 2010, 2:32 pm
Teva Pharmaceuticals USA, Inc., 518 F.3d 1353, 1363 (Fed. [read post]
5 Aug 2010, 2:03 pm
Pfizer, 518 F.3d at 1363; Geneva, 349 F.3d at 1385-86. [read post]
6 Nov 2013, 8:16 am
” TS Tech, 551 F.3d at 1319. [read post]
17 Oct 2007, 4:16 am
Duffy, George Washington Law Adjunct Professor Hal Wegner, Eli Lilly Senior Vice-President Robert A. [read post]
1 Dec 2009, 3:53 pm
Die Wettbewerbskommission (WEKO) verhängte laut Medienmitteilung gegen die Pharmaunternehmen Pfizer AG, Eli Lilly (Suisse) SA und Bayer (Schweiz) AG eine Busse von insgesamt CHF 5.7 Mio und verbot ihnen eine weitere Publikation ihrer Preisempfehlungen für drei Hors-Liste-Arzneimittel, weil sie mit Verkaufsstellen unzulässige Preisvereinbarungen getroffen hatten. [read post]
